BM
Brandywine Managers Portfolio holdings
AUM
$101M
This Quarter Return
+27.54%
1 Year Return
+24.43%
3 Year Return
+74.73%
5 Year Return
+125.12%
10 Year Return
+356.43%
AUM
$91.3M
AUM Growth
+$32.1M
(+54%)
Cap. Flow
+$17.8M
Cap. Flow
% of AUM
19.45%
Top 10 Holdings %
Top 10 Hldgs %
80.45%
Holding
44
New
6
Increased
5
Reduced
5
Closed
2
Top Buys
| 1 |
UiPath
PATH
|
$8.77M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
$7.46M |
| 3 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$586K |
| 4 |
CrowdStrike
CRWD
|
$305K |
| 5 |
DocuSign
DOCU
|
$250K |
Top Sells
| 1 |
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
|
$201K |
| 2 |
Natera
NTRA
|
$68.3K |
| 3 |
10x Genomics
TXG
|
$63.5K |
| 4 |
Intuitive Surgical
ISRG
|
$54.7K |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$49.8K |
Sector Composition
| 1 | Technology | 52.71% |
| 2 | Healthcare | 10.9% |
| 3 | Consumer Staples | 1.14% |
| 4 | Financials | 0.83% |
| 5 | Consumer Discretionary | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mobileye
MBLY
$11.1B
| $566K | 0.62% |
13,067
| – | – |
|
|
27
10x Genomics
TXG
$1.66B
| $564K | 0.62% |
10,073
-1,135
| -10% | -$63.5K |
|
28
Snowflake
SNOW
$76.5B
| $507K | 0.56% |
2,549
| – | – |
|
29
Structure Therapeutics
GPCR
$1.14B
| $489K | 0.54% |
12,007
+1,007
| +9% | +$41K |
|
30
Guardant Health
GH
$8.11B
| $387K | 0.42% |
14,303
-1,630
| -10% | -$44.1K |
|
|
SMAR
31
DELISTED
Smartsheet Inc.
SMAR
| $368K | 0.4% |
7,700
| – | – |
|
32
Relay Therapeutics
RLAY
$709M
| $350K | 0.38% |
31,807
| – | – |
|
33
Unity
U
$16.5B
| $340K | 0.37% |
8,327
| – | – |
|
34
Roblox
RBLX
$92.5B
| $331K | 0.36% |
7,241
| – | – |
|
35
AbCellera Biologics
ABCL
$1.19B
| $325K | 0.36% |
56,976
| – | – |
|
36
Prime Medicine
PRME
$595M
| $292K | 0.32% |
32,977
| – | – |
|
|
37
DocuSign
DOCU
$15.3B
| $250K | 0.27% |
+4,211
| New | +$250K |
|
38
Beam Therapeutics
BEAM
$1.9B
| $220K | 0.24% |
+8,067
| New | +$220K |
|
39
SentinelOne
S
$6.01B
| $217K | 0.24% |
+7,900
| New | +$217K |
|
40
Denali Therapeutics
DNLI
$2.24B
| $206K | 0.23% |
+9,601
| New | +$206K |
|
41
Fulcrum Therapeutics
FULC
$353M
| $176K | 0.19% |
26,127
| – | – |
|
42
Seer Inc
SEER
$114M
| $86.4K | 0.09% |
+44,552
| New | +$86.4K |
|
|
OLK
43
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| – | – |
-13,600
| Closed | -$201K |
|
|
CELL
44
DELISTED
PhenomeX Inc. Common Stock
CELL
| – | – |
-29,772
| Closed | -$29.7K |
|